MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too
Add BT as a preferred source
MARKET watchers believe tax incentives proposed by the Monetary Authority of Singapore’s (MAS) equities market review group will appeal to regional companies across a wide range of industries, including biotech, fintech and renewable energy.
“Sectors that rely on long-term capital, high-growth equity, and sustained liquidity post-listing stand to benefit the most,” said Kelvin Lee, co-founder and CEO of investment platform Alta.
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants as well. These firms often require long-term capital and investor confidence – qualities that Singapore’s financial ecosystem can provide, Ooi Chee Keong, Forvis Mazars Singapore partner and capital markets head, told The Business Times.
TRENDING NOW
Simba ordered to pay S$700,000 in damages to indoor skydiving operator Altitude Xperience for trespass
Lazada cuts about 5% of workforce as part of review across South-east Asia markets
Singtel sells S$1 billion in Gulf Development shares
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
